-葡萄糖共运输体2抑制剂的使用以及在进行大动脉置换手术后的结果
Xander Jacquemyn1, Irsa Hasan1, Takuya Ogami1
1UPMC Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA; Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
The Journal of thoracic and cardiovascular surgery
|March 14, 2026
概括
-葡萄糖携带载体2抑制剂 (SGLT2i) 改善了手术大动脉置换 (SAVR) 患者的生存率和降低了中风风险. 这项现实研究表明,SGLT2i疗法对这种特定的心血管患者群体有好处.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学 是一个学科.
背景情况:
- -葡萄糖共运输体2抑制剂 (SGLT2i) 在心血管结局方面显示出已被证明的好处.
- 在接受大动脉置换手术 (SAVR) 的严重大动脉狭窄症 (AS) 患者中,SGLT2i的效果尚未得到充分证实.
研究的目的:
- 评估SGLT2抑制剂在接受SAVR的患者中使用SGLT2抑制剂的临床结果.
- 评估SGLT2i对该人口死亡率,中风和心力衰竭住院治疗的影响.
主要方法:
- 对2930名接受SAVR或SAVR与CABG (2014-2025) 的患者进行了回顾性审查.
- 包括标准:严重的AS,LVEF≤40%,eGFR25-75,或2型糖尿病.
- 倾向性得分匹配用于将SGLT2i用户 (n=85) 与非用户进行比较.
主要成果:
- 在匹配后,SGLT2i使用与5年全因死亡率显著降低 (13.8%与25.8%,p=0.012) 相关.
- 在SGLT2i使用者中观察到降低了中风发病率 (2.0%对19.3%,p=0.046).
- 在心房动或再住院率方面没有发现显著差异.
结论:
- 在外科AVR患者的外科SGLT2抑制剂治疗与改善5年生存率和降低中风风险有关.
- 这些发现是产生假设的,需要在未来的随机试验中进一步调查.
相关概念视频
Aneurysm IV: Nursing Management
567
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
567
Aortic Regurgitation III: Medical Management
534
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
534
Kidney Transplant II: Surgical Procedure
675
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
675
Cardiomyopathy VII: Pre and Post Operative Nursing Management
414
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
414


